XEN 45 Gel Stent Implantation in Open Angle Glaucoma: 5-Year Results of a Prospective Study

被引:5
|
作者
Torbey, Julien [1 ]
Paillard, Archibald [1 ]
Rao, Harsha L. [2 ]
Gillman, Kevin [1 ]
Bravetti, Giorgio E. [1 ]
Mermoud, Andre [1 ]
Mansouri, Kaweh [1 ,3 ,4 ]
机构
[1] Glaucoma Res Ctr, Montchoisi Clin, Swiss Visio Network, Lausanne, Switzerland
[2] Narayana Nethralaya, Hulimavu, Bangalore, India
[3] Univ Colorado, Sch Med, Dept Ophthalmol, Denver, CO USA
[4] Montchoisi Clin, Swiss Visio Glaucoma Res Ctr, Ave Servan 38, CH-1006 Lausanne, Switzerland
关键词
glaucoma; microinvasive glaucoma surgery (MIGS); XEN 45 gel stent; surgery; open angle; anterior segment; INTRAOCULAR-PRESSURE; PHACOEMULSIFICATION; SURGERY;
D O I
10.1097/IJG.0000000000002302
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Pr & eacute;cis: XEN 45 Gel Stent is safe and effective for 3 years. The study results provide useful insight into the outcome of XEN 45 Gel Stent surgery over 5 years in daily clinical practice.Purpose: To evaluate 5-year outcomes of XEN 45 gel stent implantation (XEN) in patients with open angle glaucoma.Methods: This is a prospective, single-center, interventional study. XEN implantation either alone (XEN) or combined with phacoemulsification (Phaco + XEN) was performed on 170 consecutive eyes (126 patients) with uncontrolled intraocular pressure (IOP) or disease progression despite medical treatment. "Complete" surgical success at 60 months was defined as unmedicated IOP <= 15 mm Hg and a relative IOP reduction >= 20% from medicated baseline, while "qualified" success allowed fewer ocular hypotensive medications than at baseline. Other definitions of success with various IOP targets were also analyzed. Secondary outcomes included mean IOP and IOP-lowering medication changes and rates of reoperations.Results: Mean age was 78.1 +/- 9.2 years, and 70.3% were female. Mean medicated IOP decreased from 19.8 +/- 7.7 mm Hg [19.6 +/- 7.1 (XEN) vs. 19.8 +/- 7.0 mm Hg (Phaco+XEN)] at baseline to 12.6 +/- 3.1 mm Hg [12.5 +/- 3.1 (XEN) vs. 12.6 +/- 3.1 (Phaco+XEN)] at 5 years (-37.0%; P < 0.001). Medications decreased from 2.0 +/- 1.3 [2.0 +/- 1.3 (XEN) vs. 2.0 +/- 1.3 (Phaco+XEN)] to 0.8 +/- 1.1 [0.8 +/- 1.1 (XEN) vs. 0.8 +/- 1.1 (Phaco + XEN)] (-60%; P<0.001). Needling was performed in 84 eyes (49%), and 19.4% underwent a secondary surgical intervention. Complete success at 3 years was a strong predictor of success at 5 years (odds ratio: 3.06, P<0.01), while needling was associated with higher rates of failure (odds ratio: 3.6, P<0.01).Conclusions: At 5 years, XEN gel stent implantation was a safe procedure and achieved clinically meaningful IOP and medication reduction. Success at 3 years is a predictor of success at 5 years. Needling correlates with higher failure rates.
引用
收藏
页码:909 / 917
页数:9
相关论文
共 50 条
  • [31] XEN® Gel Stent in Medically Refractory Open-Angle Glaucoma: Results and Observations After One Year of Use in the United States
    Andrew G. Kalina
    Paul H. Kalina
    Morgan M. Brown
    Ophthalmology and Therapy, 2019, 8 : 435 - 446
  • [32] Efficacy of Needling Revision After XEN Gel Stent Implantation: A Prospective Study
    Midha, Neha
    Gillmann, Kevin
    Chaudhary, Ankita
    Mermoud, Andre
    Mansouri, Kaweh
    JOURNAL OF GLAUCOMA, 2020, 29 (01) : 11 - 14
  • [33] Results of fluorouracil-augmented Xen45 implantation in primary open-angle and pseudoexfoliation glaucoma
    Baser, Esin Fatma
    Seymenoglu, Recep Goktug
    INTERNATIONAL OPHTHALMOLOGY, 2021, 41 (03) : 945 - 955
  • [34] Four-Year Outcome of XEN 45 Gel Stent Implantation in a Swedish Population
    Busch, Tobias
    Skiljic, Dragana
    Rudolph, Thiemo
    Bergstrom, Anders
    Zetterberg, Madeleine
    CLINICAL OPHTHALMOLOGY, 2023, 17 : 1897 - 1910
  • [35] Comparison of Clinical Outcomes with Open Versus Closed Conjunctiva Implantation of the XEN45 Gel Stent
    Do, Anna
    McGlumphy, Elyse
    Shukla, Aakriti
    Dangda, Sonal
    Schuman, Joel S.
    V. Boland, Michael
    Yohannan, Jithin
    Panarelli, Joseph F.
    Craven, E. Randy
    OPHTHALMOLOGY GLAUCOMA, 2021, 4 (04): : 343 - 349
  • [36] Efficacy and safety of XEN 45 gel stent alone or in combination with phacoemulsification in advanced open angle glaucoma patients: 1-year retrospective study
    Teresa Laborda-Guirao
    Juan M Cubero-Parra
    Antonio Hidalgo-Torres
    International Journal of Ophthalmology, 2020, (08) : 1250 - 1256
  • [37] XEN45 gel stent in the treatment of pigmentary glaucoma: A two-year follow-up
    Gassel, Caroline J.
    Nasyrov, Emil
    Wenzel, Daniel A.
    Voykov, Bogomil
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2025, 35 (01) : 172 - 180
  • [38] Effectiveness and safety of the XEN45 gel stent compared to trabeculectomy in primary open-angle glaucoma: the Gold-Standard Pathway Study
    Ahmed, Iqbal K.
    Vera, Vanessa
    Stalmans, Ingeborg
    Fea, Antonio Maria
    Mansouri, Kaweh
    Gu, Xuemin
    Craven, Earl Randy
    Reitsamer, Herbert A.
    BMJ OPEN OPHTHALMOLOGY, 2025, 10 (01):
  • [39] Efficacy of XEN gel stent implantation combined with mitomycin C injection in the treatment of open-angle glaucoma: a meta-analysis
    Feng, Hong
    Zhang, Zhonghong
    INTERNATIONAL OPHTHALMOLOGY, 2024, 44 (01)
  • [40] Urgent Management of Secondary Glaucoma in Uveitis Using the Xen-45 Gel Stent
    Qureshi, Amreen
    Jones, Nicholas P.
    Au, Leon
    JOURNAL OF GLAUCOMA, 2019, 28 (12) : 1061 - 1066